France In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by By Test Type, Product, Usability, Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology and Other Applications) and End-users

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

In vitro diagnostic tests are the tests used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes. The rising prevalence of chronic disease has been the primary driver for the growth of this market. This rising prevalence has increased the demand for early and effective diagnostic tests. The rising prevalence of chronic illnesses have also increased the use of point-of-care (POC) diagnostics. Moreover, the increasing awareness and acceptance of personalized medicine and companion diagnostics have also helped he market growth.

Scope of the report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as Diabetes and Cancer.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Other Techniques
By Product
Instrument
Reagent
Other Product
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Other Applications
By End-users
Diagnostic Laboratories
Hospitals and Clinics
Other End-users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Cancer is expected to Cover a Large Share of the Market

A cancer biomarkers are indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Such biomarkers are be assayed using in-vitro diagnostic tests in non-invasively collected biofluids like blood or serum.

As per the data by the French national cancer institute, the reported cases of cancer have increased drastically among both men and women. As per a 2019 report by the Institute, the number of cancer cases reported have increased by 65% in men and 95% in women in the past 30 years. Therefore as the cancer incidence is further expected to rise in future, the demand for in-vitro diagnostics for early diagnosis is also expected to rise.

Graph.png

Competitive Landscape

France is a developed region with well-structured healthcare system. As a result, many players in the in-vitro diagnostics market are present in the country. Moreover, some domestic players have also been competing in the France market. These factors have made the region very competitive.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

      3. 4.2.3 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Other Techniques

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Product

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Other Applications

    5. 5.5 By End-users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End-users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMerieux

      4. 6.1.4 Bio-Rad Laboratories, Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 QIAGEN N.V.

      8. 6.1.8 Siemens Healthcare GmbH

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 Thermo Fischer Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The France In-Vitro Diagnostics Market market is studied from 2018 - 2026.

The France In-Vitro Diagnostics Market is growing at a CAGR of 7.5% over the next 5 years.

Thermo Fischer Scientific Inc, QIAGEN N.V., Abbott Laboratories, Siemens Healthcare GmbH, F. Hoffmann-La Roche AG are the major companies operating in France In-Vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!